RWM
MRNA icon

RMG Wealth Management’s Moderna MRNA Stock Holding History

RMG Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.34K Hold
21
– – ﹤0.01% 473
2026
Q1 		$1.11K Hold
21
– – ﹤0.01% 535
2025
Q4 		$1.13K Hold
21
– – ﹤0.01% 379
2025
Q3 		$562 Hold
21
– – ﹤0.01% 304
2025
Q2 		$664 Buy
+21
New +$553 ﹤0.01% 302

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

RMG Wealth Management's MRNA Position: Q2 2026 in Review

RMG Wealth Management held its Moderna (MRNA) position steady in Q2 2026 at 21 shares worth $1.34K. The position accounts for ﹤0.01% of the portfolio, ranked #473.

RMG Wealth Management first reported a position in MRNA in Q2 2025 and has held it in 5 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • RMG Wealth Management held 21 shares of Moderna worth $1.34K as of Q2 2026.
  • RMG Wealth Management left its Moderna share count unchanged in Q2 2026.
  • Moderna made up ﹤0.01% of RMG Wealth Management's portfolio in Q2 2026, its #473 holding.
  • RMG Wealth Management first reported a position in Moderna in Q2 2025 and has held it in 5 quarters since.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on RMG Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.